Special Issues
Table of Content

Advances in Urological Cancer Research

Submission Deadline: 31 October 2026 View: 68 Submit to Special Issue

Guest Editors

Assoc. Prof. Xiuping Yu

Email: xiuping.yu@lsuhs.edu

Affiliation: Department of Biochemistry & Molecular Biology, LSU Health Shreveport, Shreveport, United States

Homepage:

Research Interests: prostate cancer, urological cancer

image2.jpeg


Assoc. Prof. Yunshin Albert Yeh

Email: yunshin.yeh@lsuhs.edu

Affiliation: Department of Pathology and Translational Pathobiology, Overton Brooks VA Medical Center and LSU Health Shreveport, Shreveport, United States

Homepage:

Research Interests: prostate, kidney, and urinary bladder cancers

image3 (1).png


Summary

This Special Issue will highlight recent mechanistic, translational, and therapeutic advances in urological malignancies, such as prostate, bladder, and kidney cancers. We invite original research and focused reviews that deepen mechanistic understanding, identify therapeutic vulnerabilities, and advance precision oncology across urological tumor types. We welcome original research and authoritative reviews that elucidate molecular drivers of tumor initiation, progression, therapy resistance, and clinical translation.


Topics of Interest include:
· Molecular and cellular mechanisms of urological cancer progression
· Genomic, epigenetic, and transcriptomic alterations
· Tumor microenvironment and immune regulation
· Biomarkers and therapeutic targets
· Drug resistance and treatment strategies
· Translational and preclinical models


Keywords

urological cancer, prostate cancer, bladder cancer, kidney cancer

Share Link